Repurposing drugs during the COVID-19 pandemic and beyond
- PMID: 33445955
- PMCID: PMC7814678
- DOI: 10.4155/ppa-2020-0031
Repurposing drugs during the COVID-19 pandemic and beyond
Keywords: pandemic; patent claims; pharmaceutical industry; repurposing.
Similar articles
-
Artificial intelligence in COVID-19 drug repurposing.Lancet Digit Health. 2020 Dec;2(12):e667-e676. doi: 10.1016/S2589-7500(20)30192-8. Epub 2020 Sep 18. Lancet Digit Health. 2020. PMID: 32984792 Free PMC article. Review.
-
Therapeutics for COVID-19: from computation to practices-where we are, where we are heading to.Mol Divers. 2021 Feb;25(1):625-659. doi: 10.1007/s11030-020-10134-x. Epub 2020 Sep 2. Mol Divers. 2021. PMID: 32880078 Free PMC article. Review.
-
Repositioning of Drugs to Counter COVID-19 Pandemic - An Insight.Curr Pharm Biotechnol. 2021;22(2):192-199. doi: 10.2174/1389201021999200820155927. Curr Pharm Biotechnol. 2021. PMID: 32867651 Review.
-
Drug Discovery of Small Molecules for the Treatment of COVID-19: A Review on Clinical Studies.Mini Rev Med Chem. 2021;21(12):1431-1456. doi: 10.2174/1389557521666201228145755. Mini Rev Med Chem. 2021. PMID: 33371848 Review.
-
Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV.Future Microbiol. 2021 Nov;16:1341-1370. doi: 10.2217/fmb-2021-0019. Epub 2021 Nov 10. Future Microbiol. 2021. PMID: 34755538 Free PMC article.
References
-
- World Health Organization. WHO coronavirus disease (COVID-19) dashboard. (2020). https://covid19.who.int/
-
- World Health Organization Declares COVID-19 a ‘Pandemic’. Here's what that means (2020). https://time.com/5791661/who-coronavirus-pandemic-declaration/
-
- Gilead. Gilead sciences statement on request to rescind remdesivir orphan drug designation. (2020). https://www.gilead.com/news-and-press/company-statements/gilead-sciences...
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources